Current Support
Centers for Disease Control (U01 C000630), “ORCHARDS 3: ORegon CHild Absenteeism due to Respiratory Disease Study 3” (2021-2024). Conway, Co-Investigator
Completed Support
Centers for Disease Control (U01 CK000542), “ORCHARDS 2: ORegon CHild Absenteeism due to Respiratory Disease Study 2 using influenza-like illness-specific school absenteeism as an early warning system for detecting community influenza” (2017-2021). Conway, Co-Investigator
University of Wisconsin Global Health Institute, “Etiology and Antimicrobial Resistance Patterns of Neonatal Sepsis in Jimma, Ethiopia (EARNEST)” (2018-2019). Conway, Mentor to Daniele Gusland, MD
Sanofi Pasteur, “Surveillance program to determine product specific rates of invasive Hib disease” (2015-2019). Conway, Co-Investigator
Sanofi Pasteur, “Surveillance for rates of pertussis disease among persons birth through 59 months of age receiving Pentacel® or other pertussis vaccines” (2009-2019). Conway, PI
Infectious Diseases Society of America (travel grant), “IDWeek 2017” (2017). Joseph McBride, fellow; Conway, Mentor
Centers for Disease Control (U01 CK000336), “ORCHARDS: “ORegon CHild Absenteeism due to Respiratory Disease Study” (2013-2017). Conway, Co-Investigator
GlaxoSmithKline, “Safety and tolerability of GSK 1557484A vaccine in adults at occupational risk for influenza A (H5N1) exposure” (2013-2015). Conway, Co-Investigator
UW Global Health Initiative, “Mobile phone-disseminated health information – Malawi and Uganda” (2013-2015). Conway, Co-Investigator
Merck, “Kenya immunization managers’ training programme through global training network” (2008-2011). Conway, Co-Investigator
University of Wisconsin-Madison Center for Global Health Field Project, “Nurse implemented adolescent HIV education in Kenya” (2007-2008). Conway, Co-Mentor & Advisor